A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval

Inclusion Criteria: * 1\. Males or females, of any race, between 18 and 55 years of age, inclusive, at Screening. * 2\. Body mass index (BMI) between 18.0 and 33.0 kg/m2, inclusive, at Screening * 3\. In good health Exclusion Criteria: * 1\. An uninterpretable or abnormal ECG at Screening and/or Check in * 2\. History of risk factors for Torsades de Pointes * 3\. sustained supine systolic blood pressure \>140 mmHg or \<90 mmHg * 4\. Unstable cardiovascular disease, including recent myocardial infarction or cardiac arrhythmia. * 5\. Female subjects who are pregnant (or planning to become pregnant within 90 days after the final dose administration) or are currently lactating * 6\. Subjects who, in the opinion of the Investigator (or designee), should not participate in this study